Expertise in
12
conditions

Yuemin M. Nan

No. 139 Ziqiang Road, 
Shijiazhuang, CN 
Expertise in
12
conditions
No. 139 Ziqiang Road, 
Shijiazhuang, CN 

Overview

Yuemin Nan practices practicing medicine in Shijiazhuang, China.

Nan is highly rated in 12 conditions, according to our data. Their clinical expertise encompasses Cirrhosis, Hepatitis, Hepatitis B, and Dubin-Johnson Syndrome.

They are actively involved in clinical research, co-authoring 148 peer reviewed articles and participating in 2 clinical trials.

Locations

No. 139 Ziqiang Road, Shijiazhuang, 050051, China
Other Locations
No. 139, Ziqiang Road, Shijiazhuang, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Drugs: AK105 Injection, Anlotinib Hydrochloride Capsules, Sorafenib Tosylate Tablets
Study Phase: Phase 3
Effect of Entecavir Treatment on Regression and Long-term Disease Outcome in Patients With HBV-induced Liver Fibrosis and Cirrhosis (Regress Extension Study)
Effect of Entecavir Treatment on Regression and Long-term Disease Outcome in Patients With HBV-induced Liver Fibrosis and Cirrhosis (Regress Extension Study)
Enrollment Status: Unknown
Publish Date: April 28, 2021
Intervention Type: Drug
Study Drug: Entecavir
Study Phase: Phase 4
View 1 Less Clinical Trial

148 Total Publications

Analyzing research advances in single-cell sequencing technology for immunopathological mechanisms in acute-on-chronic liver failure
Analyzing research advances in single-cell sequencing technology for immunopathological mechanisms in acute-on-chronic liver failure
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: June 29, 2026

Frequently Asked Questions about Yuemin M. Nan

Is Yuemin M. Nan a top-rated expert for Cirrhosis?

MediFind is an objective health platform that identifies experts based on real-world data. Yuemin M. Nan is classified as an Distinguished expert for Cirrhosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yuemin M. Nan participate in research or clinical trials?

Yes. Yuemin M. Nan has published 148 articles and abstracts on conditions like Cirrhosis. You can view a list of Yuemin M. Nan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Nan's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile